Boxer Capital Management »

Abivax SA F shares owned by Boxer Capital Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Boxer Capital Management from 13F filings

Historical chart of Boxer Capital Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Boxer Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Boxer Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $10M 120k 84.90

More positions owned by Boxer Capital Management

Tango Therapeutics (TNGX)
Uniqure Nv SHS (QURE)
Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Kodiak Sciences (KOD)
Ptc Therapeutics I (PTCT)
Amylyx Pharmaceuticals (AMLX)
Urogen Pharma (URGN)
Merus N V (MRUS)
Cytokinetics Com New (CYTK)
Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Nektar Therapeutics Com New (NKTR)
Crescent Biopharma (CBIO)
Inovio Pharmaceuticals Com Shs (INO)

View all positions for Boxer Capital Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F